Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Acadia Healthcare Company (ACHC) Cash from Operations (2016 - 2025)

Acadia Healthcare Company (ACHC) has disclosed Cash from Operations for 16 consecutive years, with 86293000.0 as the latest value for Q4 2025.

  • On a quarterly basis, Cash from Operations fell 173.94% to 86293000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was 131898000.0, a 1.7% increase, with the full-year FY2025 number at 131898000.0, up 1.7% from a year prior.
  • Cash from Operations was 86293000.0 for Q4 2025 at Acadia Healthcare Company, down from 73210000.0 in the prior quarter.
  • In the past five years, Cash from Operations ranged from a high of 171148000.0 in Q2 2024 to a low of 321285000.0 in Q1 2024.
  • A 5-year average of 73948850.0 and a median of 103981500.0 in 2021 define the central range for Cash from Operations.
  • Peak YoY movement for Cash from Operations: soared 356.92% in 2021, then plummeted 823.48% in 2024.
  • Acadia Healthcare Company's Cash from Operations stood at 97846000.0 in 2021, then rose by 16.04% to 113544000.0 in 2022, then grew by 2.43% to 116304000.0 in 2023, then increased by 0.34% to 116701000.0 in 2024, then plummeted by 173.94% to 86293000.0 in 2025.
  • Per Business Quant, the three most recent readings for ACHC's Cash from Operations are 86293000.0 (Q4 2025), 73210000.0 (Q3 2025), and 133504000.0 (Q2 2025).